AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| TTW | Ann: Changes to TTW Board of Directors | 24/04/18 | 8 | 508 | |||
|
|||||||
| TTW | Ann: GTT Appointed as Corporate Advisors & New Project Search | 23/04/18 | 5 | 391 | |||
|
|||||||
| TTW | Ann: Appendix 3B | 23/04/18 | 0 | 38 | |||
|
|||||||
| TTW | Ann: Initial Director's Interest Notice | 23/04/18 | 0 | 33 | |||
|
|||||||
| TTW | Ann: Final Director's Interest Notice | 23/04/18 | 0 | 32 | |||
|
|||||||
| TTW | Ann: Becoming a substantial holder | 23/04/18 | 12 | 1.9K | |||
|
|||||||
| TTW | Ann: Quarterly Activities Report | 23/04/18 | 2 | 215 | |||
|
|||||||
| TTW | Ann: Quarterly Cashflow Report | 23/04/18 | 0 | 58 | |||
|
|||||||
See All Discussions
ASX News